Clinical Trials in Portland

Showing 6281-6300 of 10,048 trials

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

NCT00694759

The purpose of this study is to determine if insulin resistance (how well the body uses insulin and clears sugar) can affect cortisol levels in normal healthy women and women with polycystic ovary syndrome of all body weights.

Polycystic Ovary Syndrome

Oregon Health and Science University37 participantsStarted Oct 2006

Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

NCT02239120

This trial will enroll approximately 6,000 patients with recent embolic stroke of unknown source (ESUS). Patients will be randomized to dabigatran or acetylsalicyclic acid (ASA) (1:1 ratio) and have visits every three months. The study doctor may prescribe blinded concomitant ASA for pts with coronary artery disease but this is not mandatory. All Adverse Events (AEs), Serious Adverse Events (SAEs), outcome events will be recorded. The trial will conclude when the required number of stroke events are positively adjudicated which is estimated to take 3 years (including 2.5 years of enrollment).

StrokeSecondary Prevention

Boehringer Ingelheim5,390 participantsStarted Nov 2014

Phoenix, Arizona, United States • Beverly Hills, California, United States • El Cajon, California, United States +566 more locations

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Find Trials by Condition in Portland

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

Evaluation of Safety and Efficacy of Using EndoClear-Endoscopic Lens Cleaning Device

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device

Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Acupuncture and Nausea/Vomiting in Pediatric Patients

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Synchronized Immunization NotifiCations

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer